HOME Top Market Reports Transplant Diagnostics Market by Technology (PCR, SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing, Microarray), Products & Services (Instruments, Reagents), Application (Blood Profiling, Infectious Disease Testing), End User (Hospitals) - Global forecast 2021

Transplant Diagnostics Market by Technology (PCR, SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing, Microarray), Products & Services (Instruments, Reagents), Application (Blood Profiling, Infectious Disease Testing), End User (Hospitals) - Global forecast 2021

By: marketsandmarkets.com
Publishing Date: January 2017
Report Code: MD 4870

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global transplant diagnostics market is estimated to reach USD 4.36 Billion by 2021, growing at a CAGR of 7.0% during the forecast period. Factors such as the growing number of solid organ, tissue, and stem cell transplantation procedures; ongoing technological advancements in the field of genetics; and growing awareness among healthcare professionals about the benefits offered by molecular assay techniques are propelling the growth of the global market. High cost of transplant diagnostic products, limited medical reimbursements for organ donation & transplant procedures, and reluctance for organ donation among the public across developing & less-developed countries are the major factors restraining the growth of the market.

Emerging markets offer high growth opportunities for market players operating in the transplant diagnostics market. Rising incidence of chronic and infectious diseases, increasing awareness related to transplant diagnostic procedures, and continuously rising healthcare expenditure in the Asia-Pacific region are the key factors propelling the demand for transplant diagnostic products in emerging nations. In order to leverage the high growth opportunities in these emerging nations, leading market players are expanding their presence in these countries.

Transplant Diagnostics Market

To know about the assumptions considered for the study, download the pdf brochure

In 2015, Thermo Fisher Scientific, Inc. (U.S.) held the leadership position in the global transplant diagnostics market. Over the past three years, the company has adopted new product launches, product approvals, product enhancements, and strategic acquisitions and agreements as its key business strategies to ensure its dominance in this market. Bio-Rad Laboratories, Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Immucor, Inc. (U.S.), bioMérieux S.A. (France), Becton Dickinson and Company (U.S.), CareDx (U.S.), Illumina, Inc. (U.S.), and GenDx (Netherlands) are the other key players in the market.

Target Audience

  • Transplant diagnostics HLA Typing Product Manufacturing Companies
  • Healthcare Service Providers (Including Hospitals, and Transplant Centers and Blood Transfusion Centers)
  • Research and Development (R&D) Companies
  • Commercial Service Providers
  • Diagnostic Laboratories
  • Clinical Research Organizations (CROs)
  • Research Laboratories and Academic Institutes
  • Market Research and Consulting Firms

Scope of the Report

This research report categorizes the transplant diagnostics market into the following segments:

Transplant Diagnostics Market, by Technology

  • Molecular Assay
    • PCR Based
      • Real Time PCR
      • Sequence Specific Primer (SSP) PCR
      • Sequence Specific Oligonucleotide (Sso) PCR
      • Other PCR Technologies
    • Sequencing Based
      • Sanger’s Sequencing
      • Next Generation Sequencing (NGS)
      • Others Sequencing Technologies
  • Non-molecular Assay

Transplant Diagnostics Market, by Products and Services

  • Instruments
  • Reagents and Consumables 
  • Software and Services

Transplant Diagnostics Market, by Application

  • Research Applications
  • Diagnostic Applications
    • Infectious Disease Diagnostics
    • Histocompatibility Testing
    • Blood Profiling

Transplant Diagnostics Market, by End User

  • Commercial Service Providers
  • Hospitals and Transplant Centers
  • Research Laboratories and Academic Institutes

Transplant Diagnostics Market, by Region

  • North America
    • U.S.
  • Europe
  • Asia-Pacific
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the transplant diagnostics market report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies

Geographical Analysis

  • Further breakdown of the North American transplant diagnostics market into the U.S. and Canada
  • Further breakdown of the European transplant diagnostics market into Germany, France, the U.K., and Rest of Europe (RoE)
  • Further breakdown of the APAC transplant diagnostics market into Japan, China, India, and Rest of APAC (RoAPAC)

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Opportunity Indicators
           2.2.1 Healthcare Expenditure Patterns
           2.2.2 Rapid Growth in Geriatric Population
           2.2.3 Rising Incidence and Prevalence of Cancer
           2.2.4 Growing Burden of Cardiovascular Diseases
           2.2.5 Organ Donations and Transplantations
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation

3 Executive Summary (Page No. - 36)

4 Premium Insights (Page No. - 41)
    4.1 Global Transplant Diagnostics Market Overview
    4.2 Global Transplant Diagnostic Technology Market, By Region (2016)
    4.3 Global Transplant Diagnostics Product and Services Market, By Region (2016-2021)
    4.4 Global Transplant Diagnostic Applications Market, By Region (2016-2021)
    4.5 Global Transplant Diagnostic Market, By End User (2016–2021)

5 Market Overview (Page No. - 46)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Rising Number of Solid Organ, Soft-Tissue, and Stem Cell Transplantation Procedures
                    5.2.1.2 Technological Advancements
                    5.2.1.3 Growing Public-Private Investments and Funding
                    5.2.1.4 Rising Incidence of Chronic and Infectious Diseases
           5.2.2 Key Market Restraints
                    5.2.2.1 High Cost of NGS and PCR-Based Devices
                    5.2.2.2 Limited Medical Reimbursements for Organ Donation and Transplantation Procedures
           5.2.3 Key Market Opportunities
                    5.2.3.1 Technological Shift From Serological Assays to Gene-Based Donor-Recipient Profiling
                    5.2.3.2 Untapped Opportunities in Emerging Markets
                    5.2.3.3 Increasing Public Awareness About Organ Donation and Transplantation in Developed Countries
           5.2.4 Key Market Challenges
                    5.2.4.1 Significant Gap Between Number of Organs Donated and Organs Required Annually

6 Industry Insights (Page No. - 58)
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Industry Trends
           6.3.1 Integration of Advanced Technologies With Molecular Assay Procedures
           6.3.2 Development of Biomarkers for Transplantation Procedures
    6.4 Porter’s Five Forces Analysis
           6.4.1 Threat of New Entrants
           6.4.2 Threat of Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry

7 Transplant Diagnostics Market, By Technology (Page No. - 64)
    7.1 Introduction
    7.2 Molecular Assay Technologies
           7.2.1 PCR-Based Molecular Assay Technologies
                    7.2.1.1 Real-Time PCR
                    7.2.1.2 Sequence-Specific Primer-PCR (SSP-PCR)
                    7.2.1.3 Sequence-Specific Oligonucleotide-PCR (SSO-PCR)
                    7.2.1.4 Other PCR Technologies
           7.2.2 Sequencing-Based Molecular Assay Technologies
                    7.2.2.1 Sanger Sequencing
                    7.2.2.2 Next-Generation Sequencing (NGS)
                    7.2.2.3 Other Sequencing Technologies
    7.3 Non-Molecular Assay Technologies

8 Transplant Diagnostics Market, By Products & Services (Page No. - 79)
    8.1 Introduction
    8.2 Reagents and Consumables
    8.3 Instruments
    8.4 Software and Services

9 Transplant Diagnostics Market, By Application (Page No. - 85)
    9.1 Introduction
    9.2 Diagnostic Applications
           9.2.1 Infectious Disease Diagnostics
           9.2.2 Histocombatibility Testing
           9.2.3 Blood Profiling
    9.3 Research Applications

10 Transplant Diagnostics Market, By End User (Page No. - 93)
     10.1 Introduction
     10.2 Commercial Service Providers
     10.3 Hospitals and Transplant Centers
     10.4 Research Laboratories and Academic Institutes

11 Transplant Diagnostics Market, By Region (Page No. - 100)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
     11.3 Europe
     11.4 Asia-Pacific
     11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. - 119)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Scenario
             12.3.1 Strategic Benchmarking
                        12.3.1.1 Pipeline Development and Product Commercialization
     12.4 Recent Developments
             12.4.1 New Product Launches, Approvals, and Product Enhancement
             12.4.2 Agreements, Partnerships, and Collaborations
             12.4.3 Acquisition
             12.4.4 Expansion
             12.4.5 Other Developments

13 Company Profiles (Page No. - 128)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     13.1 Introduction
     13.2 Thermo Fisher Scientific Inc.
     13.3 Bio-Rad Laboratories, Inc.
     13.4 F. Hoffman-La Roche Limited
     13.5 Qiagen N.V.
     13.6 Immucor, Inc.
     13.7 Biomérieux SA
     13.8 Illumina, Inc.
     13.9 Becton Dickinson and Company
     13.10 Caredx, Inc.
     13.11 Gendx

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 174)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Introducing RT: Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports


List of Tables (66 Tables)

Table 1 Total Cost of Transplant Procedures in the U.S.: By Organ Transplantation Stages (Including Transplant Diagnosis and Monitoring)
Table 2 Global Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 3 Market Size, By Region, 2014-2021 (USD Million)
Table 4 Global Market Size for Molecular Assay Technologies, By Type, 2014-2021 (USD Million)
Table 5 Market Size for Molecular Assay Technologies, By Region, 2014-2021 (USD Million)
Table 6 Global Market Size for PCR-Based Molecular Assay Technologies, By Type, 2014-2021 (USD Million)
Table 7 Market Size for PCR-Based Molecular Assay Technologies, By Region, 2014-2021 (USD Million)
Table 8 Market Size for Real-Time PCR Technology, By Region, 2014-2021 (USD Million)
Table 9 Market Size for SSP-PCR Technology, By Region, 2014-2021 (USD Million)
Table 10 Market Size for SSO-PCR Technology, By Region, 2014-2021 (USD Million)
Table 11 Market Size for Other PCR Technologies, By Region, 2014-2021 (USD Million)
Table 12 Global Market Size for Sequencing-Based Molecular Assay Technologies, By Type, 2014-2021 (USD Million)
Table 13 Market Size for Sequencing-Based Molecular Assay Technologies, By Region, 2014-2021 (USD Million)
Table 14 Market Size for Sanger Sequencing, By Region, 2014-2021 (USD Million)
Table 15 Market Size for NGS Technology, By Region, 2014-2021 (USD Million)
Table 16 Market Size for Other Sequencing Technologies, By Region, 2014-2021 (USD Million)
Table 17 Market Size for Non-Molecular Assay Technologies, By Region, 2014-2021 (USD Million)
Table 18 Global Market Size, By Products & Services, 2014-2021 (USD Million)
Table 19 Market Size, By Region, 2014-2021 (USD Million)
Table 20 Transplant Diagnostic Reagents and Consumables Market Size, By Region, 2014-2021 (USD Million)
Table 21 Transplant Diagnostic Instruments Market Size, By Region, 2014-2021 (USD Million)
Table 22 Transplant Diagnostic Software and Services Market Size, By Region, 2014-2021 (USD Million)
Table 23 Global Market Size, By Application, 2014-2021 (USD Million)
Table 24 Market Size, By Region, 2014-2021 (USD Million)
Table 25 Global Market Size for Diagnostic Applications, By Type, 2014-2021 (USD Million)
Table 26 Market for Diagnostic Applications, By Region, USD Million (2016-2021)
Table 27 Market Size for Infectious Diseases Diagnostic Applications, By Region, 2014-2021 (USD Million)
Table 28 Market Size for Histocompatibility Testing, By Region, 2014-2021 (USD Million)
Table 29 Transplant Diagnostics Market Size for Blood Profiling Applications, By Region, 2014-2021 (USD Million)
Table 30 Transplant Diagnostics Market Size for Research Applications, By Region, 2014-2021 (USD Million)
Table 31 Global Transplant Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 32 Transplant Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 33 Transplant Diagnostics Market Size for Commercial Service Providers, By Region, 2014–2021 (USD Million)
Table 34 Transplant Diagnostics Market Size for Hospitals and Transplant Centers, By Region, 2014–2021 (USD Million)
Table 35 Transplant Diagnostics Market Size for Research Laboratories and Academic Institutes, By Region, 2014–2021 (USD Million)
Table 36 Transplant Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 37 North America: Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 38 North America: Molecular Assay-Based Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 39 North America: Transplant Diagnostics Market Size, By Products and Services, 2014-2021 (USD Million)
Table 40 North America: Transplant Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 41 North America: Transplant Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 42 U.S.: Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 43 U.S.: Molecular Assay-Based Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 44 U.S.: Transplant Diagnostics Market Size, By Products and Services, 2014-2021 (USD Million)
Table 45 U.S.: Transplant Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 46 U.S.: Transplant Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 47 Europe: Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 48 Europe: Molecular Assay-Based Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 49 Europe: Transplant Diagnostics Market Size, By Products and Services, 2014-2021 (USD Million)
Table 50 Europe: Transplant Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 51 Europe: Transplant Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 52 Asia-Pacific: Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 53 Asia-Pacific: Molecular Assay-Based Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 54 Asia-Pacific: Transplant Diagnostics Market Size, By Products and Services, 2014-2021 (USD Million)
Table 55 Asia-Pacific: Transplant Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 56 Asia-Pacific: Transplant Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 57 RoW: Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 58 RoW: Molecular Assay-Based Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 59 RoW: Transplant Diagnostics Market Size, By Products and Services, 2014-2021 (USD Million)
Table 60 RoW: Transplant Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 61 RoW: Transplant Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 62 Top New Product Launches, Approvals, and Product Enhancement (2013–2016)
Table 63 Top Agreements, Partnerships, and Collaborations (2013–2016)
Table 64 Top Acquisitions (2013–2016)
Table 65 Top Expansions (2013–2016)
Table 66 Top Other Developments (2013–2016)


List of Figures (55 Figures)

Figure 1 Research Design
Figure 2 Healthcare Expenditure Across Major Countries: 2000–2014
Figure 3 Healthcare Expenditure Across Major Regions: 2000–2014
Figure 4 Healthcare Spending Matrix: Key Markets (2014)
Figure 5 Increase in Geriatric Population, By Country (2011–2030)
Figure 6 Increase in the Proportion of the Elderly in the Overall Population, By Country (2011–2030)
Figure 7 Percentage Increase in Geriatric Population, By Region (1980–2010 vs 2010–2040)
Figure 8 Global Burden of Cancer, By Region (2005–2030)
Figure 9 Number of New Cancer Cases, By Country (2012–2020)
Figure 10 Global Burden of Cardiovascular Diseases, By Region (2005–2030)
Figure 11 Number of Live and Cadaver Organ Donations, By Country (2010–2014)
Figure 12 Bottom-Up Approach: Transplant Diagnostics Instruments Market
Figure 13 Bottom-Up Approach: Transplant Diagnostic Reagents and Consumables Market
Figure 14 Top-Down Approach
Figure 15 Data Triangulation
Figure 16 Assumptions of the Study
Figure 17 Real-Time PCR Technology is Poised to Be the Fastest Growing Transplant Diagnostic Technology Market During 2016-2021
Figure 18 Reagents and Consumables Transplant Diagnostic Products Market Till 2021
Figure 19 Infectious Disease Diagnostics is Poised to Be the Fastest Growing Transplant Diagnostic Application Segment Till 2021
Figure 20 Hospitals and Transplant Centers are Poised to Be the Fastest Growing Transplant Diagnostic End Users Segment During 2016-2021
Figure 21 North America to Dominate the Global Transplant Diagnostic Industry During 2016-2021
Figure 22 Growing Number of Transplantation Procedures to Drive the Market Growth for Transplant Diagnostic Products
Figure 23 North America is Expected to Dominate the Transplant Diagnostic Technologies Market in 2016
Figure 24 Reagents and Consumables to Dominate the Transplant Diagnostics Products Market During the Forecast Period
Figure 25 Infectious Disease Dignostics is Expected to Command the Largest Share of Transplant Diagnostic Applications Market in 2016
Figure 26 Hospitals and Transplant Centers to Dominate the Transplant Diagnostics End Users Market During the Forecast Period
Figure 27 Transplant Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 28 Number of Organ Transplant Procedures in the U.S., 2012–2015
Figure 29 Percentage Change in Annual Healthcare Expenditure — Developed vs Developing Countries (2010–2015)
Figure 30 Value Chain Analysis: Major Value is Added to the Overall Product Pricing During the R&D Phase
Figure 31 Porter’s Five Forces Analysis: Transplant Diagnostics Market (2015)
Figure 32 Molecular Assay Technology Segment to Grow Faster Than Non-Molecular Assay Techniques Till 2021
Figure 33 Real-Time PCR to Dominate PCR-Based Transplant Diagnostic Technology Market During the Study Period
Figure 34 NGS to Dominate Sequencing-Based Transplant Diagnostic Technologies Market Till 2021
Figure 35 Instruments is Poised to Be the Fastest Growing Transplant Diagnostic Products Segment During 2016-2021
Figure 36 Infectious Disease Diagnostics to Dominate the Transplant Diagnostics Application Market During the Study Period
Figure 37 Hospitals and Transplant Centers Poised to Be the Fastest Growing End User Segment in Transplant Diagnostic Industry Till 2021
Figure 38 North America: Transplant Diagnostics Market Snapshot (2016-2021)
Figure 39 Europe: Transplant Diagnostics Market Snapshot (2016-2021)
Figure 40 Asia-Pacific: Transplant Diagnostics Market Snapshot (2016-2021)
Figure 41 RoW: Transplant Diagnostics Market Snapshot (2016-2021)
Figure 42 Agreements, Partnerships, and Collaborations, Key Growth Strategies Adopted By Market Players From 2012 to 2016
Figure 43 Global Transplant Diagnostics Market Ranking, Key Player (2015)
Figure 44 Inorganic Strategies to Assist in the Market Growth of Leading Transplant Diagnostic Product Manufacturers
Figure 45 Strategic Benchmarking of the Top 5 Market Players (2015)
Figure 46 Geographic Revenue Mix of the Top 5 Market Players (2015)
Figure 47 Company Snapshot: Thermo Fisher Scientific Inc.
Figure 48 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 49 Company Snapshot: F. Hoffman-La Roche Ltd.
Figure 50 Company Snapshot: Qiagen N.V.
Figure 51 Company Snapshot: Immucor, Inc.
Figure 52 Company Snapshot: Biomérieux SA
Figure 53 Company Snapshot: Illumina, Inc.
Figure 54 Company Snapshot: Becton, Dickinson and Company
Figure 55 Company Snapshot: Caredx, Inc.

The global transplant diagnostics market is expected to reach a value of USD 4.36 Billion by 2021, growing at a CAGR of 7.0% during the forecast period. Factors such as the growing number of solid organ, tissue, and stem cell transplantation procedures; ongoing technological advancements in the field of genetics; and growing awareness among healthcare professionals about the benefits offered by molecular assay techniques are propelling the growth of the global market. High cost of transplant diagnostic products, limited medical reimbursements for organ donation & transplant procedures, and reluctance for organ donation among the public across developing & less-developed countries are the major factors restraining the growth of the market.

On the basis of technology, the transplant diagnostics market is segmented into non-molecular assay and molecular assay (PCR based and sequencing based). The PCR based segment is expected to account for the largest share of the market in 2016. This growth can be attributed to the expanding distribution networks of key PCR manufacturers across emerging countries, increasing private funding to develop innovative PCR-based products, and ongoing development and commercialization of innovative PCR-based products for donor-recipient compatibility testing.

On the basis of application, the market is segmented into research applications and diagnostic applications (includes infectious diseases diagnostics, histocompatibility testing, and blood profiling). In 2016, the infectious diseases diagnostics segment is expected to account for the largest share of the transplant diagnostics application market owing to factors such as increasing incidence of infectious diseases, growing adoption of advanced molecular techniques for pathogen detection, and increased public-private funding for the development of innovative infectious disease diagnostic technologies.

On the basis of region, the transplant diagnostics market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global market is expected to be dominated by North America. Significant growth potential offered by the North American market is attributed to the high adoption of advanced diagnostic technologies among healthcare professionals in the region, increasing prevalence of target diseases, and continuous technological advancements in the field of genomic analysis.

Transplant Diagnostics Market

As of 2015, the global transplant diagnostics market was dominated by Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Immucor, Inc. (U.S.), bioMérieux S.A. (France), Becton Dickinson and Company (U.S.), CareDx (U.S.), Illumina, Inc. (U.S.), and GenDx (Netherlands), among others.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo